Regulatory Update

Malaysia MDA Change Management Guidance 2026 for Registered Medical Devices

Malaysia’s Medical Device Authority (MDA) has published the first edition of MDA/GD/0072 Change Management for Registered Medical Devices, which will replace MDA/GD/0020 following the official launch of MedCAST 3.0. Until implementation takes effect, the current change notification guidance remains applicable. Companies should review the new guidance and prepare for upcoming regulatory process changes.

Published on:
May 19, 2026

Malaysia’s Medical Device Authority (MDA) has published the first edition of MDA/GD/0072 Change Management for Registered Medical Devices. The new guidance document will eventually replace the current MDA/GD/0020 Change Notification for Registered Medical Devices.

The publication of the new MDA change management guidance represents an important regulatory update for medical device manufacturers, authorized representatives, importers, and distributors managing registered medical devices in Malaysia.

Key Update on MDA/GD/0072

MDA has clarified that the newly published MDA/GD/0072 Change Management for Registered Medical Devices has not yet been implemented.

The guidance document will only take effect following the official launch of MedCAST 3.0.

Until the implementation becomes effective:

  • MDA/GD/0020 Change Notification for Registered Medical Devices remains applicable
  • Existing change notification requirements remain in force
  • Industry stakeholders should continue following current procedures

This transition period allows companies sufficient time to review the new requirements and prepare internal regulatory processes before the formal implementation of MedCAST 3.0.

Impact on Industry Stakeholders

The publication of the first edition guidance document is significant for companies involved in Malaysia medical device registration and lifecycle management.

Manufacturers and regulatory teams should begin reviewing the new guidance to understand potential procedural and documentation changes that may apply once MedCAST 3.0 is officially launched.

Early preparation may help stakeholders:

  • Streamline future change management submissions
  • Align internal quality and regulatory systems
  • Prepare documentation and compliance workflows
  • Minimize implementation disruptions during transition

What Companies Should Do Now

Industry stakeholders are encouraged to:

  • Continue complying with MDA/GD/0020 Change Notification for Registered Medical Devices
  • Review the newly published MDA/GD/0072 Change Management for Registered Medical Devices
  • Monitor future announcements regarding MedCAST 3.0 implementation
  • Assess internal readiness for upcoming regulatory process changes

Internal Reference

For additional guidance on Malaysia medical device regulatory compliance, stakeholders may also refer to:

External Reference

Official guidance documents issued by the Medical Device Authority (MDA):

Subscribe to newsletter
Subscribe to receive the latest blog posts to your inbox every week.
By subscribing, you agree to our Terms and Conditions.
Thank you for subscribing!
Oops! Something went wrong while submitting the form.
Malaysia registration starting at $2,000/year
AI-powered dossier compilation and local representation, all for a flat annual fee.
Get an estimate
Read more

Latest News

Browse our news hub featuring company announcements, regulatory updates, and industry insights to keep you informed and ahead of the curve.

Let's Talk,
Anywhere You Are.

Whether looking for more information or ready to partner with us, we're here to guide you through every step of the regulatory process.

Contact us